GF Xinde Investment Management
VC Fund
Guangzhou, China
GF Xinde Investment Management is a VC fund in Guangzhou focused on Manufacturing and Health Care. GF Xinde Investment Management Co., Ltd. was established in 2008 through the approval of the China Securities Commission on Direct Investment, with registered capital of RMB 2.3 billion. GF Xinde is one of the leading direct investment brokerages in China. Through a deep understanding of capital markets, known for integrity, professional service, and possessing an abundance of industry resources; GF Xinde not only provides strong financial support to investing corporations, but imparts a wealth of advanced management experience and access to a national business network. Supported by the comprehensive strengths of GF Securities, GF Xinde will assist the invested enterprise with establishing a strategic, long-term plan for growth by increasing their management efficiency, building the ideal capital structure, and a strong platform necessary for a successful IPO. All possible types of investments, merger and acquisitions, business, and technical cooperation opportunities will be provided for the invested enterprise. This will ensure the mutual benefits of both the Company and the invested enterprise are financially sound and increase the overall investment value through business synergies. As a direct investment brokerage, GF Xinde provides distinct advantages in regards to investment resources, market research, professional expertise, mergers and acquisitions and IPO experience. As of December 2014, GF Xinde’s accumulated total assets under management exceeded RMB 5 billion, with 16 successful IPOs, ranking first amongst the industry in both scale and number of successful public offerings. Currently, the Company has successfully created a number of diverse management funds: mezzanine funds, merger and acquisition funds, private equity funds, and other investment funds, covering but not limited to a wide range of industries, such as medicine, consumer stocks, and the internet.
- Total investments:
- 156
- Last investment:
- Lead investor:
- 26%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries GF Xinde Investment Management invests in
Stages GF Xinde Investment Management invests in
Countries GF Xinde Investment Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Angel
- $456k–$1.6M
- Series A
- $1.4M–$42M
- Series B
- $9.2M–$141M
Investment Focus
Industry
- Manufacturing 26 (17%)
- Health Care 15 (10%)
- Biotechnology 15 (10%)
- Software 13 (8%)
- Artificial Intelligence 13 (8%)
Stage
- Series A 49 (31%)
- Series B 44 (28%)
- Angel 15 (10%)
- Seed 12 (8%)
- Series C 12 (8%)
Country
- China 123 (79%)
- United States 8 (5%)
- Hong Kong 3 (2%)
- Japan 1 (1%)
- Australia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Li Chen
Partner
|
Partner | Total investments: 5 | Find email | |
Xiaoying Mai
Investment Director
|
Investment Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gaowei Medicine
|
Gaowei Medicine is a drug discovery platform for developing new drugs for key intractable diseases such as cancer and neurological diseases. | Seed / Oct 14, 2026 | |
| D-Robotics is a provider of robotic computing solutions. We're committed to delivering paradigm-shifting products that drive efficiency, simplify development and accelerate innovation. | $400M / Series C / Sep 17, 2026 | ||
Sequence Technology
|
Sequence Technology emphasizes in the production of polymer materials used in the semiconductor manufacturing process. | $14.9M / Series B / Sep 17, 2026 | |
| Xuntu Technology is a leading data intelligence provider specializing in investment research and decision-making solutions. | $44.7M / Series B / Sep 10, 2026 | ||
| Deepin Intelligent Control is a smart energy innovation company. | Series B / Sep 08, 2026 | ||
| WorldCom Hengqi is an operating system & solution provider of intelligent operating systems using AI, big data & cloud technologies. | $74.5M / Series B / Sep 07, 2026 | ||
| UnitQC is a China‑based quantum technology company focused on trapped‑ion quantum computing systems and related products. | Series A / Aug 03, 2026 | ||
| Xihu Xinchen is a technology company focusing on the research and development of artificial intelligence services. | Series B / Aug 03, 2026 | ||
| SeaArt is an AI creativity platform that provides tools for generating and editing images, videos, audio, and interactive AI character chats. The service includes text-to-image art generation, text-to-video and image-to-video creation, and an AI chatbot assistant with customizable characters. SeaArt also offers AI audio synthesis with multiplevoices, workflow control through ComfyUI, model training and hosting for Stable Diffusion based models, and swift AI tools for upscaling and filtering media. A built-in community enables sharing, remixing, challenges, and creator incentive programs for monetizing AI-generated works. | $14.7M / Series B / Jul 13, 2026 | ||
| Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | $29.5M / Series A / Jun 30, 2026 | ||
| See all 156 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does GF Xinde Investment Management invest in?
GF Xinde Investment Management invests primarily in Manufacturing, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 156 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does GF Xinde Investment Management invest in?
GF Xinde Investment Management typically joins rounds of $456k–$1.6M at Angel, $1.4M–$42M at Series A and $9.2M–$141M at Series B. These are whole funding-round sizes, not GF Xinde Investment Management's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds GF Xinde Investment Management took part in.
How do I contact GF Xinde Investment Management?
Public channels for GF Xinde Investment Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at GF Xinde Investment Management?
The team at GF Xinde Investment Management includes Li Chen (Partner) and Xiaoying Mai (Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
